Mark S. Graham

Array ( [id] => 5520873 [patent_doc_number] => 20090028854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'sc(Fv)2 SITE-DIRECTED MUTANT' [patent_app_type] => utility [patent_app_number] => 11/916351 [patent_app_country] => US [patent_app_date] => 2006-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 14810 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20090028854.pdf [firstpage_image] =>[orig_patent_app_number] => 11916351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5135614 [patent_doc_number] => 20070077243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'Method for making humanized antibodies' [patent_app_type] => utility [patent_app_number] => 11/444791 [patent_app_country] => US [patent_app_date] => 2006-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 35497 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20070077243.pdf [firstpage_image] =>[orig_patent_app_number] => 11444791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5759616 [patent_doc_number] => 20060210561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Dosages for treatment with anti-EGFR antibodies' [patent_app_type] => utility [patent_app_number] => 11/443943 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 26019 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20060210561.pdf [firstpage_image] =>[orig_patent_app_number] => 11443943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 131213 [patent_doc_number] => 07700299 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-20 [patent_title] => 'Method for predicting the response to a treatment' [patent_app_type] => utility [patent_app_number] => 11/438033 [patent_app_country] => US [patent_app_date] => 2006-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15628 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/700/07700299.pdf [firstpage_image] =>[orig_patent_app_number] => 11438033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5699601 [patent_doc_number] => 20060216285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies' [patent_app_type] => utility [patent_app_number] => 11/429363 [patent_app_country] => US [patent_app_date] => 2006-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 36358 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216285.pdf [firstpage_image] =>[orig_patent_app_number] => 11429363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5704806 [patent_doc_number] => 20060193854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies' [patent_app_type] => utility [patent_app_number] => 11/429361 [patent_app_country] => US [patent_app_date] => 2006-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 36366 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20060193854.pdf [firstpage_image] =>[orig_patent_app_number] => 11429361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5704804 [patent_doc_number] => 20060193852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Novel CD19xCD3 specific polypeptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/418058 [patent_app_country] => US [patent_app_date] => 2006-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 16888 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20060193852.pdf [firstpage_image] =>[orig_patent_app_number] => 11418058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 359423 [patent_doc_number] => 07485302 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-03 [patent_title] => 'Treatment with anti-ErbB2 antibodies and chemotherapeutic agents' [patent_app_type] => utility [patent_app_number] => 11/429043 [patent_app_country] => US [patent_app_date] => 2006-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 21 [patent_no_of_words] => 36352 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/485/07485302.pdf [firstpage_image] =>[orig_patent_app_number] => 11429043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4994188 [patent_doc_number] => 20070009533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Treatment of cancer patients exhibiting activation of the P-glycoprotein efflux pump mechanism' [patent_app_type] => utility [patent_app_number] => 11/417984 [patent_app_country] => US [patent_app_date] => 2006-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14918 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20070009533.pdf [firstpage_image] =>[orig_patent_app_number] => 11417984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5056388 [patent_doc_number] => 20070059310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Therapeutic combination compositions and methods of using same' [patent_app_type] => utility [patent_app_number] => 11/416542 [patent_app_country] => US [patent_app_date] => 2006-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21435 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20070059310.pdf [firstpage_image] =>[orig_patent_app_number] => 11416542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6391429 [patent_doc_number] => 20100303760 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2010-12-02 [patent_title] => 'TREATMENT AND/OR PREVENTION OF CANCER AND/OR ARTHRITIS' [patent_app_type] => utility [patent_app_number] => 11/912432 [patent_app_country] => US [patent_app_date] => 2006-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11331 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0303/20100303760.pdf [firstpage_image] =>[orig_patent_app_number] => 11912432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6391429 [patent_doc_number] => 20100303760 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2010-12-02 [patent_title] => 'TREATMENT AND/OR PREVENTION OF CANCER AND/OR ARTHRITIS' [patent_app_type] => utility [patent_app_number] => 11/912432 [patent_app_country] => US [patent_app_date] => 2006-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11331 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0303/20100303760.pdf [firstpage_image] =>[orig_patent_app_number] => 11912432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5732833 [patent_doc_number] => 20060257950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Use of protein UBC13 as a marker for breast cancer' [patent_app_type] => utility [patent_app_number] => 11/404201 [patent_app_country] => US [patent_app_date] => 2006-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7931 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257950.pdf [firstpage_image] =>[orig_patent_app_number] => 11404201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 267018 [patent_doc_number] => 07566542 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-28 [patent_title] => 'Use of protein ASC as a marker for breast cancer' [patent_app_type] => utility [patent_app_number] => 11/404218 [patent_app_country] => US [patent_app_date] => 2006-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10017 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/566/07566542.pdf [firstpage_image] =>[orig_patent_app_number] => 11404218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5125499 [patent_doc_number] => 20070237770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Novel compositions and methods in cancer' [patent_app_type] => utility [patent_app_number] => 11/403116 [patent_app_country] => US [patent_app_date] => 2006-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66493 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20070237770.pdf [firstpage_image] =>[orig_patent_app_number] => 11403116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8305658 [patent_doc_number] => 08227194 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-24 [patent_title] => 'Monoclonal antibodies with binding specificity for response gene to complement 32 (RGC-32)' [patent_app_type] => utility [patent_app_number] => 11/911103 [patent_app_country] => US [patent_app_date] => 2006-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20457 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11911103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9166220 [patent_doc_number] => 08591897 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-26 [patent_title] => 'Anti-ERBB2 antibody adjuvant therapy' [patent_app_type] => utility [patent_app_number] => 11/400638 [patent_app_country] => US [patent_app_date] => 2006-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 32029 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11400638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4950122 [patent_doc_number] => 20080306248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Conjugate of Biomacromolecule with Bioreductive and Preparative Method Thereof' [patent_app_type] => utility [patent_app_number] => 11/916539 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4226 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20080306248.pdf [firstpage_image] =>[orig_patent_app_number] => 11916539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363204 [patent_doc_number] => 08252267 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'DKKL-1 splice product modulators for cancer diagnosis and therapy' [patent_app_type] => utility [patent_app_number] => 11/887692 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 26 [patent_no_of_words] => 39641 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11887692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485290 [patent_doc_number] => 20090275055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'Monoclonal Antibodies Specific to Denatured Human Class I Leucocyte Antigens' [patent_app_type] => utility [patent_app_number] => 11/887297 [patent_app_country] => US [patent_app_date] => 2006-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3824 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275055.pdf [firstpage_image] =>[orig_patent_app_number] => 11887297 [rel_patent_id] =>[rel_patent_doc_number] =>)